Gene: PASK
Official Full Name: PAS domain containing serine/threonine kinaseprovided by HGNC
Gene Summary: This gene encodes a member of the serine/threonine kinase family that contains two PAS domains. Expression of this gene is regulated by glucose, and the encoded protein plays a role in the regulation of insulin gene expression. Downregulation of this gene may play a role in type 2 diabetes. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Nov 2011]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO29753 | PASK Knockout cell line (HeLa) | Human | PASK | 1:3~1:6 | Negative | Online Inquiry |
KO29754 | PASK Knockout cell line (HCT 116) | Human | PASK | 1:2~1:4 | Negative | Online Inquiry |
KO29755 | PASK Knockout cell line (HEK293) | Human | PASK | 1:3~1:6 | Negative | Online Inquiry |
KO29756 | PASK Knockout cell line (A549) | Human | PASK | 1:3~1:4 | Negative | Online Inquiry |
PASK Gene Knockout Cell Lines are genetically modified cell lines in which the PASK (PAS domain containing serine/threonine kinase) gene has been specifically disrupted or deleted using advanced CRISPR/Cas9 technology. These cell lines serve as valuable tools for studying the biological role of PASK in various cellular processes, including metabolism, cell growth, and signal transduction. By eliminating the expression of this critical gene, researchers can investigate how its absence affects cellular functions, providing greater insight into its contribution to physiological and pathological states.
The mechanisms underlying the function of PASK involve its role in sensing cellular energy levels and modulating glucose metabolism, making it significant in studies related to diabetes and metabolic disorders. The knockout of this gene allows for the thorough exploration of alternate signaling pathways and compensatory mechanisms in cell model systems, facilitating a better understanding of metabolic diseases and potential therapeutic targets.
In scientific research and clinical applications, PASK Gene Knockout Cell Lines provide a straightforward approach to elucidate the gene's functions and evaluate the effects of candidate drugs or genetic manipulations on metabolic pathways. Compared to traditional knockdown approaches, which may only partially inhibit gene expression, knockout cell lines offer a complete lack of gene activity, ensuring more reliable experimental outcomes.
The advantages of using PASK Gene Knockout Cell Lines include their reproducibility and the ability to generate a more precise understanding of pathology associated with PASK dysregulation, therefore appealing to both academic and pharmaceutical researchers seeking to advance their work in metabolic disease research. By offering a robust platform for research, these cell lines present significant value for understanding complex metabolic networks and the development of therapeutic modalities.
Our company brings extensive expertise in genetic engineering and product development for research applications, ensuring that researchers and clinicians have access to high-quality biological tools that drive innovation in their fields.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.